Where do I get my information from: http://armandoh.org/resource
“Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.
Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.
The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes.”
Atelectasis: Etiology, Clinical Features, Pathology, pathophysiology, Diagnosis, and Treatment
Atelectasis is a loss of lung volume that may be caused by a variety of ventilation disorders, for instance, bronchial injury or an obstructive mass such as a tumor. It may be categorized as obstructive, nonobstructive, postoperative, or rounded. Clinical features depend on the severity and extent of atelectasis, ranging from no symptoms to respiratory distress. Physical examination reveals a dull note on percussion and diminished breathing sounds over the affected area. On x-ray, the atelectatic section of the lung appears condensed and, due to decreased lung volume, may extend to the surrounding tissue. This effect can lead to an elevated diaphragm and mediastinal shift to the affected side. Treatment depends on the underlying cause. Complications of atelectasis include pneumonia or, depending on the extent of disease, respiratory failure.
The MetaNeb® System provides patients an effective and consistent therapy to prevent and treat pulmonary atelectasis while delivering operational efficiencies to healthcare providers. The MetaNeb® delivers three therapies with one device; lung expansion with Continuous Positive Expiratory Pressure (CPEP), secretion mobilization with Continuous High Frequency Oscillation (CHFO) and aerosol delivery.
Learn more about The MetaNeb® System at: http://www.hill-rom.com/usa/Products/Category/Respiratory-Care/MetaNeb-System/
The information contained in these videos is provided for educational purposes only and is not intended nor implied to be a substitute for professional medical advice. You assume full responsibility for how you choose to use this information. Please speak with your healthcare provider about any questions you may have regarding a medical condition.
Hill-Rom retains all right, title, and interest in and to the video, and retains the right to demand that you immediately cease use of the video and unembed the video. Hill-Rom may discontinue or disable videos you have embedded at any time for any reason. You will not misrepresent the content contained in the video or use it in conjunction with price comparisons, in derogatory comparisons or in negative comparisons, with Hill-Rom’s competitor’s products, or in derogatory or negative commentaries about Hill-Rom’s products – doing so may subject you to liability. Any and all claims made by you regarding the use, operation, quality, etc. of Hill-Rom’s products are your own, and you shall be responsible for ensuring that all such claims comply fully with all applicable federal, state and local laws.
